Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice?

Journal article

Peer reviewed

Anne Marie Dupuy, Anne-Sophie Bargnoux, Marion Morena, Emilie Lauret, Jean Claude Souberbielle, Etienne Cavalier and Jean-Paul Cristol

Clinical Chemistry and Laboratory Medicine

05/09/2018

PMID: 30183664

Abstract

third generation

second generation

PTH

clinical impact

url

Find in HALView

1 Record Views

Title: Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice?
Creators - without role: Anne Marie Dupuy - Centre Hospitalier Régional Universitaire [Montpellier]
Anne-Sophie Bargnoux - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Marion Morena - Centre National de la Recherche Scientifique
Emilie Lauret - Stress Oxydant et Pathologies Métaboliques
Jean Claude Souberbielle - Assistance Publique – Hôpitaux de Paris
Etienne Cavalier - University of Liège
Jean-Paul Cristol - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Publication Details: Clinical Chemistry and Laboratory Medicine
Identifiers: 9938982109311
Academic Unit: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Language: English
Resource Type: Journal article
Local Fields: hal-01870358